ZEB1 and breast carcinoma: In breast cancer cells, PRMT1 plays a crucial role in mediating the asymmetric dimethylation of histone H4 at arginine 3 within the ZEB1 promoter, facilitating the transcriptional expression of ZEB1, a key factor in the EMT process [46].